Monitoring immunoglobulin heavy chain and T-cell receptor gene rearrangement in cfDNA as minimal residual disease detection for patients with acute myeloid leukemia

The present study aimed to examine whether monoclonal immunoglobulin heavy chain (IGH) or T-cell receptor (TCR) gene rearrangement in cell-free DNA (cfDNA) may be used for minimal residual disease (MRD) monitoring in patients with acute myeloid leukemia (AML). Monoclonal IGH and TCR rearrangement in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Ling, Chen, Jiao, Huang, Xiaobing, Li, Yanxing, Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036514/
https://www.ncbi.nlm.nih.gov/pubmed/30008930
http://dx.doi.org/10.3892/ol.2018.8966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036514/
https://www.ncbi.nlm.nih.gov/pubmed/30008930
http://dx.doi.org/10.3892/ol.2018.8966

Ejemplares similares